Ads
related to: tecentriq breast cancer- IMFINZI Indication
Learn About The Approval &
View Data From The HIMALAYA Study.
- The HIMALAYA Study
View Clinical Data From The
Trial & See The Indication.
- IMFINZI Safety Data
Adverse Events From The HIMALAYA
Study. Visit Site To Learn More.
- Resources & Support
Download Educational Materials &
Read Financial Assistance Info.
- Mechanism Of Action
View IMFINZI MOA To See If It May
Be An Option For Your Patients.
- Official Physician Site
Visit Site For Approval Info
& Other IMFINZI Indications.
- IMFINZI Indication
Search results
What Is Triple-Negative Breast Cancer?
Verywell Health via Yahoo News· 1 year agoTriple-negative breast cancer (TNBC) is a type of breast cancer that does not have hormone receptors. TNBC is diagnosed in 10% to 15% of all cases of...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 6 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Oncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag
Zacks via Yahoo Finance· 1 year agoOncolytics Biotech (ONCY) receives a fast-track designation from the FDA for pelareorep combined...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
Zacks via Yahoo Finance· 2 months agoGenprex (GNPX) gains 9.5% after expanding clinical study sites in the United States for the early to...
Ads
related to: tecentriq breast cancer
